Researchers continue to excited about the medication , a novel dual treatment showing promising outcomes in initial trials for weight loss . It works by modulating both pathways : GLP-1 and GIP, these, when engaged , assist control cravings and boost metabolism . Early reports suggest substantial size loss and potential benefits for individuals fac